Search | Page 6 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant

    ... lacking suitable identical donors and those who are refractory to immunosuppressive therapy (IST). The current study evaluated ...

    Research Article last updated 02/03/2017 - 9:40am.

  2. Platelet drug shows clinical benefits for severe, unresponsive aplastic anemia

    ... However, we are designing a new trial for patients with refractory aplastic anemia that includes children. We also currently have a ... untreated moderate aplastic anemia in adults, another for refractory aplastic anemia in adults (an extension of the published study), and ...

    Interview last updated 07/06/2012 - 3:42pm.

  3. Recent advances in the treatment of lower-risk non-del(5q) myelodysplastic syndromes (MDS)

    ... restricted to select patients. New strategies for ESA- refractory or relapsed patients include lenalidomide , alone or in ...

    Research Article last updated 12/09/2016 - 2:50pm.

  4. Left main crossover stenting in a patient with severe thrombocytopenia due to aplastic anemia

    ... 11 × 103/μL, hemoglobin 6.4 g/dL). Refractory heart failure persisted despite repeated conservative ...

    Research Article last updated 12/09/2016 - 2:08pm.

  5. Haploidentical transplantation for pediatric patients with acquired severe aplastic anemia

    ... This result suggests that both newly diagnosed and refractory pediatric SAA patients benefit from haplo-HSCT, especially when ...

    Research Article last updated 01/24/2017 - 11:52am.

  6. Eltrombopag for the treatment of aplastic anemia: current perspectives

    ... patients. A significant proportion of patients are refractory to IST or relapse after IST. Various strategies have been ... as an encouraging and promising agent for patients with refractory AA. It has demonstrated efficacy in restoring trilineage ...

    Research Article last updated 11/01/2016 - 2:01pm.

  7. Are Myelodysplastic Syndromes Underdiagnosed in Poland? A Report by the Polish Adult Leukaemia Group

    ... age. The most frequently diagnosed MDS subtype was refractory cytopenia with multilineage dysplasia (RCMD), ...

    Research Article last updated 11/02/2016 - 10:17am.

  8. Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents

    ... myelodysplastic syndromes ineligible for or refractory to erythropoiesis-stimulating agents. PATIENTS AND METHODS: ... non-del(5q) myelodysplastic syndromes ineligible for or refractory to erythropoiesis-stimulating agents. Response to lenalidomide was ...

    Research Article last updated 07/18/2016 - 10:30am.

  9. Recent advances in the understanding of myelodysplastic syndromes with ring sideroblasts

    ... Mutations of SF3B1 occur in up to 90% of patients with refractory anaemia with unilineage dysplasia (RARS) and 70% of those with refractory cytopenia with multilineage dysplasia and ring sideroblasts ...

    Research Article last updated 08/15/2016 - 11:29am.

  10. Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes

    ... we conducted a subset analysis limited to patients with refractory anaemia with excess blasts (RAEB). In 2025 HMA-treated ...

    Research Article last updated 10/06/2016 - 11:34am.